Minerva Neurosciences
NERV
#8831
Rank
NZ$0.35 B
Marketcap
NZ$7.62
Share price
-1.12%
Change (1 day)
135.54%
Change (1 year)

Earnings for Minerva Neurosciences (NERV)

Earnings in 2026 (TTM): -NZ$0.72 Billion

According to Minerva Neurosciences 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.51 Billion a decrease over its 2024 earnings that were of NZ$2.47 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Minerva Neurosciences from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.72 Billion42.29%
2025 -NZ$0.51 Billion-20492.68%
2024 NZ$2.47 M-104.8%
2023 -NZ$51.59 Million-6.55%
2022 -NZ$55.2 Million-37.91%
2021 -NZ$88.9 Million-2764.37%
2020 NZ$3.33 M-102.61%
2019 -NZ$0.13 Billion48.37%
2018 -NZ$86.25 Million22.67%
2017 -NZ$70.32 Million31.74%
2016 -NZ$53.38 Million14.64%
2015 -NZ$46.56 Million-52.41%
2014 -NZ$97.82 Million1644.37%
2013 -NZ$5.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Incyte
INCY
NZ$3.04 B-527.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-NZ$58.26 Million-91.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
-NZ$0.38 Billion-47.62%๐Ÿ‡บ๐Ÿ‡ธ USA